An article written by our co-founders Antoine Pouppez and Pierre Pouget, and published on ADN: NeuroClues, a start-up developing a medical device based on eye-tracking,
The newsletter of this month will emphasize the latest research about Parkinson’s disease (PD) as April is Parkinson’s Awareness month
NeuroClues™ (P3Lab) awarded funding from the European Commission through the prestigious EIC Accelerator Program
In summary P3Lab is one of the 78 companies selected among 1092 applicants by the European program EIC Accelerator. The funds will enable the company
The newsletter of this month is related to the relevance of eye tracking in Deep Brain Stimulation (DBS) for Parkinson’s disease (PD).
The newsletter of this month is related to the analysis of eye movements for differential diagnosis of Multiple System Atrophy.
P3Lab receives ISO 13485:2016 certification for design and development of eye tracking devices